{"id":467,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/pt-br\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","title":{"rendered":"MK-677 \/ Ibutamoren: Estado cl\u00ednico, sinal de insufici\u00eancia card\u00edaca e quest\u00f5es materiais"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">MK-677, MK-0677 e ibutamoren s\u00e3o nomes encontrados na mesma hist\u00f3ria de desenvolvimento. A exist\u00eancia de ensaios em humanos n\u00e3o significa que o composto seja um medicamento aprovado, nem elimina ensaios que n\u00e3o demonstraram benef\u00edcios funcionais ou levantaram preocupa\u00e7\u00f5es de seguran\u00e7a.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">O que o registro mostra<\/h2><ul class=\"wp-block-list\"><li>Ibutamoren n\u00e3o \u00e9 um ingrediente ativo aprovado pelo FDA.<\/li><li>Um estudo de fratura de quadril em paciente 123 foi interrompido precocemente ap\u00f3s um sinal de insufici\u00eancia card\u00edaca congestiva.<\/li><li>A identidade e o ensaio devem distinguir a forma livre de ibutamoren do mesilato de ibutamoren.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\" alt=\"Cientista revisando dados de pesquisa do horm\u00f4nio de crescimento puls\u00e1til e IGF-1\" class=\"wp-image-459\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Ilustra\u00e7\u00e3o editorial original utilizada para identificar o tema da pesquisa. N\u00e3o representa lote de cat\u00e1logo, medicamento aprovado, resultado de ensaio ou uso cl\u00ednico.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">O limite de identidade e evid\u00eancia<\/h2><p class=\"wp-block-paragraph\">Um certificado deve indicar a forma molecular exata e n\u00e3o usar o nome original e o mesilato de forma intercambi\u00e1vel. A massa molecular, o c\u00e1lculo do ensaio e o conte\u00fado por recipiente dependem dessa escolha.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Sin\u00f4nimos na literatura<\/strong><span>MK-677, MK-0677, ibutamoren<\/span><\/div><div class=\"pim-evidence-row\"><strong>Problema de sal\/forma<\/strong><span>Ibutamoren vs mesilato de ibutamoren<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexto de seguran\u00e7a<\/strong><span>Efeitos de glicose\/insulina, edema e sinal CHF<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">O que pertence ao registro material<\/h2><p class=\"wp-block-paragraph\">Os resumos de marketing frequentemente selecionam o aumento de IGF-1 ou massa livre de gordura e omitem os resultados funcionais negativos. Uma p\u00e1gina defens\u00e1vel mant\u00e9m a hierarquia de resultados intacta e cita o estudo interrompido sobre fratura de quadril, bem como o estudo mais longo com adultos mais velhos saud\u00e1veis.<\/p><h2 class=\"wp-block-heading\">Regra editorial<\/h2><p class=\"wp-block-paragraph\">Use o nome exato da interven\u00e7\u00e3o, modelo, popula\u00e7\u00e3o e desfecho do registro citado. N\u00e3o converta uma associa\u00e7\u00e3o, mecanismo, resultado animal, registro de medicamento acabado aprovado ou teste anal\u00edtico em uma afirma\u00e7\u00e3o sobre um lote de cat\u00e1logo n\u00e3o relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>MK-677, MK-0677 e ibutamoren s\u00e3o nomes encontrados na mesma hist\u00f3ria de desenvolvimento. A exist\u00eancia de ensaios em humanos n\u00e3o significa que o composto seja um medicamento aprovado, nem elimina ensaios que n\u00e3o demonstraram benef\u00edcios funcionais ou levantaram preocupa\u00e7\u00f5es de seguran\u00e7a.<\/p>","protected":false},"author":1,"featured_media":632,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"351","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Randomized trials and FDA compounding review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"MK-677 in healthy older adults: two-year randomized trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18981485\/\",\"note\":\"Body composition, function and glucose findings; PMID 18981485.\"},{\"title\":\"MK-0677 phase IIb hip-fracture study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21067829\/\",\"note\":\"Early termination after CHF signal; PMID 21067829.\"},{\"title\":\"FDA Pharmacy Compounding Advisory Committee meeting materials\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/october-29-2024-meeting-pharmacy-compounding-advisory-committee-10292024\",\"note\":\"FDA assessment materials for ibutamoren and ipamorelin.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MK-677 Clinical Status, Safety Signals &amp; Quality Questions<\/title>\n<meta name=\"description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/pt-br\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\" \/>\n<meta property=\"og:description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/pt-br\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"wordCount\":242,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"name\":\"MK-677 Clinical Status, Safety Signals & Quality Questions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/pt-br\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Status cl\u00ednico MK-677, sinais de seguran\u00e7a e perguntas de qualidade","description":"MK-677, MK-0677 e ibutamoren s\u00e3o nomes encontrados na mesma hist\u00f3ria de desenvolvimento. A exist\u00eancia de testes em humanos n\u00e3o significa que o composto seja aprovado\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/pt-br\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_locale":"pt_BR","og_type":"article","og_title":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","og_description":"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026","og_url":"https:\/\/nhdbio.com\/pt-br\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"wordCount":242,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","url":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","name":"Status cl\u00ednico MK-677, sinais de seguran\u00e7a e perguntas de qualidade","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"MK-677, MK-0677 e ibutamoren s\u00e3o nomes encontrados na mesma hist\u00f3ria de desenvolvimento. A exist\u00eancia de testes em humanos n\u00e3o significa que o composto seja aprovado\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mat\u00e9rias-primas pept\u00eddicas e s\u00edntese personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipe T\u00e9cnica NHD","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"A equipe t\u00e9cnica NHD mant\u00e9m documenta\u00e7\u00e3o de cat\u00e1logo de uso em pesquisa e resumos de evid\u00eancias. Os artigos revisados \u200b\u200bvinculam-se a artigos revisados \u200b\u200bpor pares, registros de ensaios e registros regulat\u00f3rios, ret\u00eam resultados nulos e limita\u00e7\u00f5es de estudos e distinguem interven\u00e7\u00f5es publicadas de materiais de cat\u00e1logo. O desenho assistido por AI pode ser usado para estrutura; os links de origem e os limites das evid\u00eancias permanecem vis\u00edveis. Este trabalho n\u00e3o \u00e9 uma revis\u00e3o independente por pares ou aconselhamento m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/pt-br\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/comments?post=467"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/467\/revisions"}],"predecessor-version":[{"id":509,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/467\/revisions\/509"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media\/632"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media?parent=467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/categories?post=467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/tags?post=467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}